Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iSpecimen (ISPC) Research & Development (2020 - 2025)

Historic Research & Development for iSpecimen (ISPC) over the last 6 years, with Q3 2025 value amounting to $551104.0.

  • iSpecimen's Research & Development fell 2698.0% to $551104.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.6 million, marking a year-over-year decrease of 2712.58%. This contributed to the annual value of $3.5 million for FY2024, which is 102.68% down from last year.
  • According to the latest figures from Q3 2025, iSpecimen's Research & Development is $551104.0, which was down 2698.0% from $536311.0 recorded in Q2 2025.
  • Over the past 5 years, iSpecimen's Research & Development peaked at $967831.0 during Q4 2023, and registered a low of $361799.0 during Q2 2021.
  • Its 5-year average for Research & Development is $696008.3, with a median of $740410.0 in 2022.
  • Its Research & Development has fluctuated over the past 5 years, first skyrocketed by 7569.15% in 2022, then plummeted by 4118.93% in 2025.
  • Over the past 5 years, iSpecimen's Research & Development (Quarter) stood at $522551.0 in 2021, then skyrocketed by 41.69% to $740410.0 in 2022, then soared by 30.72% to $967831.0 in 2023, then decreased by 1.67% to $951667.0 in 2024, then crashed by 42.09% to $551104.0 in 2025.
  • Its Research & Development was $551104.0 in Q3 2025, compared to $536311.0 in Q2 2025 and $545367.0 in Q1 2025.